Advertisement
Advertisement

CSCI

CSCI logo

COSCIENS Biopharma Inc.

3.00
USD
+0.15
+5.26%
Dec 11, 09:50 UTC -5
Closed
...

COSCIENS Biopharma Inc. Profile

About

COSCIENS Biopharma Inc. is a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is based in TORONTO, ONTARIO.

Info & Links

CEO

Klaus Paulini

Headquarters

222 BAY STREET, SUITE 3000, PO BOX 53
TORONTO, A6 M5K 1E7, CANADA

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.zentaris.com

Auditor

Deloitte LLP

Share holders

14

Employees

21

COSCIENS Biopharma Inc. Statistics

Valuation Measures

Market Capitalization2

11.28M

Enterprise Value

-8.72M

Enterprise Value/EBITDA(ttm)

0.30

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.52

Price to Book(mrq)

0.54

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-67.90%

Operating Margin(ttm)

-428.43%

Profit Margin(ttm)

-35768.47%

Return on Equity(ttm)

-95.93%

Return on Invested Capital(ttm)

-129.21%

Return on Assets(ttm)

-45.66%

Income Statement

Revenue(ttm)

3.24M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

2.33M

EBITDA(ttm)3

-29.08M

Net Income Available to Common(ttm)

-23.59M

Diluted EPS(ttm)

-11.87

Share Statistics

Beta (5Y Monthly)

1.51

52-Week Change

-64.11%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

3.75M

% Held by Insiders

0.10%

% Held by Institutions

0.73%

Balance Sheet

Total Cash(mrq)

20.00M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.46%

Quick Ratio(mrq)

3.05%

Book Value Per Share(mrq)

6.41

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.72

Free Cash Flow(ytd)

-12.42M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement